Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 27,249	$ 21,338
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	886	869
Amortization of intangible assets	183	222
Deferred income tax expense	4,750	3,308
Provision for credit losses	1,588	4,958
Stock-based compensation expense	1,081	1,037
Net amortization on loan fees, costs, premiums, and discounts	792	36
Net amortization on securities premiums, discounts, and net unrealized loss on securities transferred to held-to-maturity	341	408
Net income from equity method investments	(2,072)	(153)
Net loss on sale of securities available for sale	2,774	3,086
Net gain on sale of loans	(47)	(3)
Net gain on redemption of bank-owned life insurance	0	(225)
Proceeds from sales of loans held for sale	7,084	3,459
Originations of loans held for sale	(7,357)	(1,176)
Increase in cash surrender value of bank-owned life insurance	(609)	(556)
Net gain on repurchase of subordinated debt	0	(780)
Decrease in accrued interest receivable	2,048	597
Decrease in other assets	9,985	6,403
Decrease in other liabilities	(17,414)	(7,975)
Net cash provided by operating activities	31,262	34,853
CASH FLOWS FROM INVESTING ACTIVITIES
Net increase in loans	(15,434)	(94,742)
Purchase of securities available for sale	(142,368)	(17,220)
Purchase of securities held-to-maturity	(38,918)	(98,893)
Proceeds from sales of securities available for sale	78,827	145,305
Maturities, principal payments and redemptions of securities available for sale	46,038	42,144
Maturities, principal payments and redemptions of securities held-to-maturity	61,975	21,082
Decrease (increase) in resell agreements	(81,242)	10,323
Increase in equity method investments	295	288
Decrease (increase) in FHLBNY stock, net	(214)	26,100
Purchases of premises and equipment, net	(207)	(263)
Proceeds from redemption of bank-owned life insurance	0	980
Net cash (used in) provided by investing activities	(91,248)	35,104
CASH FLOWS FROM FINANCING ACTIVITIES
Net increase in deposits	293,777	446,324
Net decrease in other borrowings	(165,246)	(440,000)
Repurchase of subordinated debt	0	(3,220)
Common stock issued under Employee Stock Purchase Plan	244	388
Repurchase of common stock	(285)	(2,425)
Dividends paid	(3,115)	(3,082)
Payments related to repurchase of common stock for equity awards	(755)	(585)
Net cash provided by (used in) financing activities	124,620	(2,600)
Increase in cash, cash equivalents, and restricted cash	64,634	67,357
Cash, cash equivalents, and restricted cash at beginning of year	90,570	63,540
Cash, cash equivalents, and restricted cash at end period	155,204	130,897
Supplemental disclosures of cash flow information:
Interest paid during the period	34,527	15,509
Income taxes paid during the period	317	291
Right-of-use assets obtained in exchange for lease liabilities	560	0
Purchase of securities available for sale, net not settled	$ 21,000	$ 0